Cathy Gwin
Senior Director, Communications
The Technical Consortium for DNA Synthesis Screening, convened by NTI | bio and the World Economic Forum (WEF), responded to the U.S. government’s request for comment on its Revised Screening Framework Guidance for Providers and Users of Synthetic Oligonucleotides.
NTI | bio team members join hundreds of global health security experts from around the world in Singapore for the second Global Health Security Conference.
Nicholas Cropper, Shrestha Rath, and Ryan Teo are the winners of the Sixth Annual Next Generation for Biosecurity Competition.
NTI and the Vienna Center for Disarmament and Nonproliferation (VCDNP) co-hosted a meeting on June 7, 2022 to explore the possibility of establishing a new “Joint Assessment Mechanism” to strengthen UN-system capabilities to investigate high-consequence biological events of unknown origin.
In a new article for the CTC Sentinel, NTI | bio Vice President Jaime Yassif explains how advances in bioscience and biotechnology are accompanied by emerging biological risks and cites the need for action to safeguard the life sciences to prevent biotechnology catastrophe.
Sign up for our newsletter to get the latest on nuclear and biological threats.
Sign up for regular updates on innovative, real-world solutions to existential threats.
{ location = 'https://www.nti.org/get-updates/' }, 300);">Get Updates